TEISHIMA, J.; INOUE, S.; HAYASHI, T.; MITA, K.; HASEGAWA, Y.; KATO, M.; KAJIWARA, M.; SHIGETA, M.; MARUYAMA, S.; MORIYAMA, H.; FUJIWARA, S. Impact of the systemic immune-inflammation index for the prediction of prognosis and modification of the risk model in patients with metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitors. Canadian Urological Association Journal, [S. l.], v. 14, n. 11, p. E582–7, 2020. DOI: 10.5489/cuaj.6413. Disponível em: https://cuaj.ca/index.php/journal/article/view/6413. Acesso em: 28 mar. 2024.